Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial

Cited by (204)

Items 101–200 of 204

1. Clinical practice guidelines for cardiovascular disease: how is depression addressed? Protocol for a systematic review
   Dana Blatch Armon, Aliki Buhayer, Kevin Dobretz, Gunther Meinlschmidt, Edouard Battegay · 2023 · BMJ Open
2. Effects of tryptophan, serotonin, and kynurenine on ischemic heart diseases and its risk factors: a Mendelian Randomization study
   Mengyu Li, Man Ki Kwok, Shirley S.M. Fong, Catherine Mary Schooling · 2020 · European Journal of Clinical Nutrition
3. Cardiovascular Imaging of Biology and Emotion
   Judith L. Meadows, Samit Shah, Matthew M. Burg, Steven E. Pfau, Robert Soufer · 2020 · Circulation Cardiovascular Imaging
4. The Impact of Anxiety and Depression Symptoms on Cardiovascular Risk Factor Control in Patients Without a History of Atherosclerotic Cardiovascular Disease
   Łukasz Pietrzykowski, Agata Kosobucka, Piotr Michalski, Michał Kasprzak, Jakub Marcin Ratajczak, Alicja Rzepka-Cholasińska, Joanna Siódmiak, Klaudyna Grzelakowska, Aldona Kubica · 2024 · Vascular Health and Risk Management
5. Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention
   Nicholas Nguyen, Katherine C Michelis · 2025 · US Cardiology Review
6. THE EFFECTS OF AGOMELATINE ON HEART RATE VARIABILITY IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS WHO SUFFERED ACUTE CORONARY SYNDROME
   Т. М. Попонина, Гундерина Ксения Ивановна, Yu. S. Poponina, М. В. Солдатенко · 2018 · Сибирский журнал клинической и экспериментальной медицины
7. Depression interventions for individuals with coronary artery disease – Cost-effectiveness calculations from an Irish perspective
   Samira Barbara Jabakhanji, Jan Rose Sørensen, Robert M. Carney, Chris M Dickens, Martin Dempster, Jonathan Gallagher, Isabela O Caramlau, Frank Doyle · 2022 · Journal of Psychosomatic Research
8. Rationale, design, and baseline data for a multicenter randomized clinical trial comparing depression screening strategies after acute coronary syndrome: The comparison of depression identification after acute Coronary Syndromes-Quality of Life and Cost Outcomes (CODIACS-QOL) trial
   Nathalie Moise, Karina W. Davidson, Ying Kuen K. Cheung, Gregory N. Clarke, Rowena J Dolor, Joan Duer-Hefele, Joseph A. Ladapo, Karen L. Margolis, Tara St. Onge, Faith Parsons et al. · 2019 · Contemporary Clinical Trials
9. Impact of depression on medication non-adherence in coronary artery disease: a systematic review and meta-analysis
   Dione Jones, Jason Tsz Shing Yue, Tu Ngoc Nguyen, Fahed Ahmad, Clara Kayei Chow · 2025 · Open Heart
10. Depression screening in patients with coronary heart disease
    Sebastian Kohlmann · 2024 · Herz
11. Pattern of Depression Among Patients of Myocardial Infarction in Karachi, Pakistan: A Cross-sectional Study
    Hasham Saeed, Fahad Khan, Syeda Fatima Mohsin, Farwa Haider Qizilbash, Tayyab Raza Fraz, Qirat Jawed, Nawaz Lashari · 2018 · Cureus
12. Heart Failure and Suicide: The Role of Depression
    Christopher M. Celano, Jeff C. Huffman · 2018 · Journal of Cardiac Failure
13. Underestimated prognostic value of depression in patients with obstructive coronary artery disease
    Quanjun Liu, Han Yin, Cheng Shi Jiang, Mingyu Xu, Yuting Liu, Anbang Liu, Haochen Wang, Bingqing Bai, Fengyao Liu, Lan Guo et al. · 2022 · Frontiers in Cardiovascular Medicine
14. The Role of Palliative Care in Cardiovascular Disease
    John Arthur McClung, William H. Frishman, Wilbert S. Aronow · 2024 · Cardiology in Review
15. Temperament and Depression After a First Acute Coronary Syndrome
    Paolo Ossola, Irene Generali, Graziana Schito, Chiara De Panfilis, Matteo Tonna, Maria Lidia Gerra, Carlo Marchesi · 2019 · The Journal of Nervous and Mental Disease
16. The Impact of Changes in Depression on Cardiovascular Outcomes in Patients With Coronary Heart Disease
    Nishant Vatsa, Josiah Bennett, Sonika Vatsa, Alireza Rahbar, Daniel A. Gold, Vardhmaan Jain, Matthew E. Gold, Alexander C. Razavi, ADITHYA K. YADALAM, Shivang Desai et al. · 2024 · JACC Advances
17. Implementing depression treatment for cardiac populations in rapidly changing contexts: Design of the hybrid effectiveness-implementation IHEART DEPCARE trial
    Andrea T. Duran, Jennifer Mizhquiri Barbecho, Kaitlin Shaw, Siqin Ye, Nohora Ospina, Samantha Simantiris, Joseph E. Schwartz, Nathalie Moise · 2025 · American Heart Journal
18. Impact of depression status and antidepressant use on mortality rates and clinical outcomes following acute myocardial infarction
    Roisin M. Sabol, Christina N. Sun, Casey A Gudenburr, Hongyi Zou, Tanya J. Fabian, Ying Xue · 2025 · Journal of Psychiatric Research
19. Cardiovascular mortality and depression: A systematic review and meta-analysis of the association with antidepressant treatment and co-morbidity
    Tiago da Silva Costa, Beth Hall, Sean Hill, Ramy Teama, Eleanor Romaine, Sharmin Ahmed, Iain McKinnon, Stuart Watson, Alan J. Bagnall, Ryan P. W. Kenny et al. · 2026 · Journal of Psychopharmacology
20. Conceptual competence in medicine: promoting psychosomatic awareness in clinics, research and education
    Dirk von Boetticher · 2025 · Frontiers in Psychiatry
21. The Impact of Antidepressants on Surgical Outcomes Among Patients With Abdominal Cancer and Comorbid Depression
    Erryk Katayama, Sidharth Iyer, Selamawit Woldesenbet, Zayed Rashid, Mujtaba Khalil, Kristen M. Carpenter, Timothy Michael Pawlik · 2025 · Psycho-Oncology
22. Association between Obsessive-Compulsive Symptoms and Long-Term Cardiac Outcomes in Patients with Acute Coronary Syndrome: Effects of Depression Comorbidity and Treatment
    Hee‐Joon Lee, Ju‐Wan Kim, Hee‐Ju Kang, Sung‐Wan Kim, Il‐Seon Shin, Young Joon Hong, Youngkeun Ahn, Myung Ho Jeong, Jin‐Sang Yoon, Jae‐Min Kim · 2019 · Psychiatry Investigation
23. Psychokardiologie: Aktuelle Leitlinien und Versorgungspraxis
    Christoph Herrmann‐Lingen · 2021 · PiD - Psychotherapie im Dialog
24. Case 9-2019: A 62-Year-Old Man with Atrial Fibrillation, Depression, and Worsening Anxiety
    Justin A. Chen, Leon M. Ptaszek, Christopher M. Celano, Scott R. Beach · 2019 · New England Journal of Medicine
25. Suicidal Ideation Predicts Functioning and Quality of Life Over One Year after Acute Coronary Syndrome
    Jae‐Min Kim, Ju‐Wan Kim, Hee‐Ju Kang, Kyung‐Yeol Bae, Sung‐Wan Kim, Il‐Seon Shin, Young Joon Hong, Youngkeun Ahn, Myung Ho Jeong, Jin‐Sang Yoon · 2019 · Psychiatry Investigation
26. Interaction effects of diabetes and brain-derived neurotrophic factor on suicidal ideation in patients with acute coronary syndrome
    Wonsuk Choi, Ju‐Wan Kim, Hee‐Ju Kang, Hee Kyung Kim, Ho-Cheol Kang, Ju‐Yeon Lee, Sung‐Wan Kim, Young Joon Hong, Youngkeun Ahn, Myung Ho Jeong et al. · 2022 · Scientific Reports
27. The effects of 5-HT on vascular endothelial dysfunction in patients with panic disorder
    Yun Feng, Xixi Li, Zijia Li, Xinyi He, Yanqing Tang, Wen Tian · 2025 · Frontiers in Cardiovascular Medicine
28. Chronic medical diseases and depressive symptoms in Europe: A study using representative data from 275,009 individuals in the third wave of the European Health Interview Survey (EHIS-3)
    Woo Ri Chae, Ronny Kuhnert, Maike Buchmann, Giselle Sarganas, Daniel Grams, Niels Michalski, Christian Otte, Ulfert Hapke · 2025 · Journal of Affective Disorders
29. Mind–heart links in ASCVD: Evidence for chronic risk, acute triggers, and clinical prevention
    Emmanuel Eroume A Egom · 2025 · Trends in Cardiovascular Medicine
30. Mental Disorders Following Implantable Cardioverter-Defibrillator Therapy
    Juwon Kim, Hyunsoo Kim, Hyunsoo Kim, Ju Youn Kim, Kyoung‐Min Park, Young Keun On, Danbee Kang, Seung‐Jung Park · 2025 · JACC. Clinical electrophysiology
31. Core symptoms in the cardiac rehabilitation phase of patients with chronic heart failure: A symptom network analysis study
    Fengfei Zhou, Bailing Zhang, Yi Lu, Qingqing Yang · 2025 · Medicine
32. Predictors and Outcomes Associated with Clinically Significant Improvements in Anxiety and Depression Symptoms Following Cardiac Rehabilitation
    Laura Hernández, Tamara M. Williamson, Tavis S. Campbell, Sandeep Aggarwal, Ross A Arena, Stephen B. Wilton, Tianqi Tao, Codie R. Rouleau · 2025 · Canadian Journal of Cardiology
33. Depression, Anxiety, and Bipolar Disorder and Atherosclerosis
    Emamuzo Obaro Otobo, Joseph D. Nguyen, Fatima Umaira Saeed, Midori Torpoco Rivers, Sinead M. Sinnott, Puja K. Mehta, Antonia V. Seligowski, Shady Abohashem, Michael Thomas Osborne · 2026 · Current Atherosclerosis Reports
34. Update Psychokardiologie
    Monika Sadlonova, Christoph Herrmann‐Lingen · 2021 · DMW - Deutsche Medizinische Wochenschrift
35. Drug classification for patients with comorbidities
    Belialov Fi · 2022 · Journal of Pharmaceutical Policy and Practice
36. Escitalopram Induced Angioedema
    Samantha L Conde, Hani Nazha, Cassandra Simpkins · 2022 · Cureus
37. The effect of escitalopram in treating mild to moderate depressive disorder and improving the quality of life in patients undergoing coronary artery bypass grafting – a double-blind randomized clinical trial
    Abdolvahab Baradaran, Mohammad Reza Khodaie Ardakani, Fatemeh Sadat Bateni, Fatemeh Asadian-Koohestani, Mohsen Vahedi, Afsaneh Aein, Nazila Shahmansouri, Gita Sadighi · 2024 · Frontiers in Psychiatry
38. Effectiveness of Paroxetine Versus Non‐Paroxetine Selective Serotonin Reuptake Inhibitors on Mortality and Heart Failure Following Myocardial Infarction: An Active Comparator Population‐Based Cohort Study
    Thomas Ravn Lassen, Péter Szentkúti, Henrik Toft Sørensen, Hans Erik Bøtker, Jens Sundbøll · 2025 · Pharmacoepidemiology and Drug Safety
39. Treating Holmes tremor with deep brain stimulation
    Martin Nevrlý, David Krahulík, Pavel Otruba, Jan Bardoň, Petr Kaňovský · 2020 · Neurologie pro praxi
40. Association of patient-reported psychosocial healthcare and risk of readmissions and mortality in patients with ischemic heart disease: A population-based cohort study
    Line Zinckernagel, Teresa Holmberg, Ann‐Dorthe Zwisler, Susanne S. Pedersen, Christina Boesgaard Graversen, Annette Kjær Ersbøll · 2022 · Journal of Psychosomatic Research
41. Operationalizing Depression Screening in Ambulatory Palliative Care: A Quality Improvement Project
    Daniel Shalev, Melissa Patterson, Yasemin S. Aytaman, Manuel A. Moya-Tapia, Craig D. Blinderman, Milagros D. Silva, M. Carrington Reid · 2022 · Journal of Pain and Symptom Management
42. Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
    Kenichi Shizukawa, Hisashi Narita, Hissei Imai, Hisashi Akiyama, Shuhei Ishikawa, Ryo Sawagashira, Tomoyuki Isoyama, Mariko Nohara, Michiyo Kawamura, Yukari Kono et al. · 2023 · Frontiers in Psychiatry
43. Intervention options: depression and cardiovascular disease during COVID-19
    Eirini Flouda, Athena Stefanatou, Tinia Apergi · 2023 · Global Cardiology
44. Medical Comorbidities of Hispanics with Mental Health Problems
    David Martinez Garza, Elliott R. Weinstein, Daniel E. Jimenez · 2022 · Springer eBooks
45. Kardiovaskuläre Erkrankungen
    Hans‐Peter Kapfhammer · 2022 · Springer eBooks
46. Chapter 20. Psychopharmacology
    Benoit H. Mulsant, Bruce G. Pollock · 2022 · American Psychiatric Association Publishing eBooks
47. Mental Health Is Heart Health: Adjusting Clinical Guidelines for Depression After Myocardial Infarction
    Christian R. Hardoy, Jonathan H. Shipley, Eric N. Kramer, Robert M. McCarron · 2023 · Harvard Review of Psychiatry
48. The Impact of Cardiac Rehabilitation on Psychosocial Factors, Functional Capacity, and Left Ventricular Function in Patients with Coronary Artery Disease: Systematic Review and Meta-Analysis
    Ali Suleiman Harbi, Kim Geok Soh, Putri Yubbu, Kim Geok Soh · 2024 · F1000Research
49. Functioning in an Illness and Quality of Life versus the Prevalence of Depression and Anxiety Disorders in Patients with High Cardiovascular Risk
    Piotr Michalski, Agata Kosobucka, Łukasz Pietrzykowski, Michał Kasprzak, Klaudyna Grzelakowska, Alicja Rzepka-Cholasińska, Aldona Kubica · 2024 · Nursing Reports
50. Compound identification of Shuangxinfang and its potential mechanisms in the treatment of myocardial infarction with depression: insights from LC-MS/MS and bioinformatic prediction
    Yize Sun, Haibin Zhao, Zheyi Wang · 2025 · Frontiers in Pharmacology
51. Best-Practice Mental Health Interventions Following Acute Cardiovascular Events
    Manuela Neves Abreu, Rui Pedro Albuquerque, Alexandra Fonseca · 2026 · Cardiology Clinics
52. The Mental Health–Acute Coronary Syndrome Continuum: Bidirectional Pathophysiological Links and Clinical Implications
    Alexandra Herlaș-Pop, Andrei-Flavius Radu, Ada Radu, Gabriela S. Bungau, Delia Mirela Ţiţ, Elena Emilia Babeş, Cristiana Bustea · 2026 · Medical Sciences
53. Association of Baseline SSRI use with post-STEMI outcomes in patients with depression
    Akash Gopal, Cassidy Kamrada, Ali Awad, Mariam Chalhoub, Jawad Basit, M. Chadi Alraies · 2026 · International Journal of Cardiology
54. Antidepressants and cardiac safety
    Scott R. Beach, Christopher M. Celano, Matthew G. Gunther, Jeff C. Huffman · 2026 · BMJ
55. Psychokardiologie 2018 – aktuelle Leitlinien und klinische Realität
    Christoph Herrmann‐Lingen · 2019 · PSYCH up2date
56. Increased Risk of Coronary Heart Disease in Patients with Anxiety Disorders: A Review of Underlying Biomarkers
    Judith Brouillette · 2019 · Biomedical Journal of Scientific & Technical Research
57. Prevention of Early Readmissions in the Chronically Medically Ill Patient
    Mark W. Ketterer · 2019 · Journal of Health Service Psychology
58. A Value Framework for Transforming Behavioral Health
    Katherine Hobbs Knutson · 2021 · NEJM Catalyst
59. Cardio-cerebral syndrome in patients with chronic heart failure
    Kseniia A. Eruslanova, Elen A. Mkhitaryan, Изюмов Андрей Дмитриевич, A. B. Seifetdinova, Yu. V. Kotovskaya, О. Н. Ткачева · 2022 · Russian neurological Journal
60. Psychosomatic Problem Areas and Comorbidities Using the Example of Coronary Heart Disease
    Christian Albus, Christoph Herrmann‐Lingen, Volker Köllner, Roland von Känel, Georg Titscher · 2022 · Springer eBooks
61. Research Progress on the Correlation between Acute Myocardial Infarction (AMI) and Depression
    秀甜 苏 · 2023 · Advances in Clinical Medicine
62. Intervention options: depression and cardiovascular disease during COVID-19
    Eirini Flouda, Athena Stefanatou, Tinia Apergi · 2023 · Global Cardiology
63. Chapter 14. Citalopram and Escitalopram
    Richard Charles Shelton · 2024 · American Psychiatric Association Publishing eBooks
64. Needs and Preferences for Remote-Delivered Mindfulness-Based Cognitive Therapy in Patients After Acute Coronary Syndrome: A Qualitative Study
    Christina M. Luberto, Sydney Crute, Amy Wang, Runnan Li, Gloria Y. Yeh, Jeff C. Huffman, Christopher M. Celano, David E. Victorson, Bettina B. Hoeppner, Elyse Richelle Park · 2024 · Global Advances in Integrative Medicine and Health
65. Mental disorders after myocardial infarction: potential mediator role for chemokines in heart-brain interaction?
    Parth Patel, Feiyan Yang, Dumitru A. Iacobaş, Lei Xi · 2024 · 老年心脏病学杂志：英文版
66. Mental Disorders in Patients with Cardiovascular Diseases. Consensus Statement by the Task Force of the Russian Society of Cardiology and the Russian Society of Psychiatrists
    Belialov Fi, Dmitry Yu. Veltishchev, Beatrice A. Volel, Natalia P. Garganeeva, F. Yu. Kopylov, N. V. Lareva, V. E. Medvedev, Sergey N Mosolov, M. M. Petrova, О. В. Петрунько et al. · 2025 · Kardiologiia
67. Electrocardiographic Changes in Patients with Depression after Using Escitalopram for a Short Period
    Raz Muhammed HamaSalih, Rebwar Ghareeb Hama · 2023 · Al Mustansiriyah Journal of Pharmaceutical Sciences
68. Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome
    Brett D. Thombs, Roy Charles Ziegelstein · 2018 · JAMA
69. Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome—Reply
    Jae‐Min Kim, Robert J. Stewart, Jin‐Sang Yoon · 2018 · JAMA
70. SSRIs in the medical subspecialty clinic: Part two
    Lawrence H. Price · 2018 · The Brown University Psychopharmacology Update
71. Composite outcomes – the devil is in the details
    Luis Eduardo Santos Fontes, Rachel Riera, Matheus Guedes Monteiro, Rafael Leite Pacheco · 2019 · Journal of Evidence-Based Healthcare
72. Psychosomatische Problemfelder und Komorbiditäten am Beispiel der koronaren Herzkrankheit
    Christian Albus, Christoph Herrmann‐Lingen, Volker Köllner, Roland von Känel, Georg Titscher · 2019 · Springer eBooks
73. Does pharmacologic treatment of depression after acute coronary syndrome reduce the risk of subsequent adverse cardiovascular outcomes?
    Kyle Herring, Julia Fashner · 2020 · Evidence-Based Practice
74. Predictors of Cardiovascular and Gastrointestinal Disorders, Inappropriate Nonsteroidal Anti-inflammatory Drug Use, and Alzheimer’s Disease and Related Dementia in Older Adults with Osteoarthritis
    Jayeshkumar Patel · 2020
75. Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome
    George S. Rust · 2018 · JAMA
76. Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome
    Frederik M. Zimmermann, Mohamed El Farissi, Pim A.L. Tonino · 2018 · JAMA
77. Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
    Jin Hwa Kim · 2021 · Diabetes & Metabolism Journal
78. Incorrect Data in Figures
    2018 · JAMA
79. Redução de efeitos cardiovasculares com o uso de antidepressivos: uma revisão da literatura.
    Mariam Walid Hamdan, Daiane Breda, Cristiane de Bortoli Rota, Camila Hoffmann Fritzen, Manuela Stracke, Nathana Massucatto Lima, Gabriela Carreiro Bento, Larissa Gonçalves Silva, Leticia Silva, Igor Fernando de Melo Cavalcante · 2023 · Brazilian Journal of Implantology and Health Sciences
80. Antidepressant Drugs: For Anyone Sad or Only for the Melancholic Depressed?
    Robert Haim Belmaker, Pesach Lichtenberg · 2023 · Springer eBooks
81. OS RISCOS DA SEMAGLUTIDA PARA PERDA DE PESO
    Cíntia da Silva dos Santos, Luíza Danielle Canedo dos Santos, Rita das Graças da Silva, Anna Maly de Leão e Neves Eduardo, Axell Donelli Leopoldino Lima, Ikaro Alves de Andrade · 2023
82. CONSULTÓRIOS FARMACÊUTICOS NO SUS - ALFENAS
    Milvia Maria Jacomini Salvi, Lívia Nunes da Silva Souza, Isadora Luziana Izidoro de Souza, Fernanda Pimentel de Lima, Yasmin Bastos Campos, Noemi Nami Kuzoka Ferreira da Silva, Letícia de Oliveira Marusso, Marina Isabel Silva PEDRO, Tiago Marques dos Reis, Luciene Alves Moreira Marques · 2023
83. REPADRONIZAÇÃO DE PRODUTOS FARMACÊUTICOS EM UM SERVIÇO DAY CLINC DE ONCOLOGIA E SEUS EFEITOS NA PERSPECTIVA FINANCEIRA E ASSISTENCIAL
    Fábio Augusto Meneses Sousa, Hiago Sousa Pinheiro, Kalysta de Oliveira Resende Borges, Poliana Pezente, Sonia da Silva Melo, Karla Fabiane de Oliveira Maia Penalber, Cairo Borges, Marcos Fraga Fortes · 2023
84. O USO OFF LABEL DE METFORMINA E FLUOXETINA PARA EMAGRECIMENTO
    Laisa Mirelle Rodrigues Simões, Mikaelly Bezerra Melo, José Israel Guerra · 2023
85. Farmácia: normas legais, aspectos empresariais e relações profissionais 2
    Débora Luana Ribeiro Pessoa · 2023
86. RISCOS À SAÚDE CAUSADO PELO USO PROLONGADO DE ANTIDEPRESSIVOS
    Samuel Henrique Inácio dos Santos, Ediany Izabelly da Silva Lima, Tibério César Lima de Vasconcelos, Cristiane Gomes Lima · 2023
87. Intervention options: depression and cardiovascular disease during COVID-19
    Eirini Flouda, Athena Stefanatou, Tinia Apergi · 2023 · Global Cardiology
88. What is the most effective and safest treatment of depression after CABG?
    Amanda Schoenfuss, Hilary Steltenpohl, Marshall Rutherford, Samantha Vouyiouklis · 2024 · Evidence-Based Practice
89. Emotional Distress (ED) & Clinical Outcomes in Cardiac Patients: Cause, Effect, or Confound?
    Mark W. Ketterer · 2024 · The American Journal of Cardiology
90. The Impact of Cardiac Rehabilitation on Psychosocial Factors, Functional Capacity, and Left Ventricular Function in PatientS with Coronary Artery Disease: Systematic Review and Meta-Analysis
    Ali Suleiman Harbi, Kim Lam Soh, Putri Yubbu, Kim Geok Soh, Salimah Japar · 2024 · F1000Research
91. Hearts and minds: treating depression in cardiac disease
    Lawrence H. Price · 2024 · The Brown University Psychopharmacology Update
92. Identification and characteristics of distressed patients with coronary heart disease and insufficiently controlled medical risk factors: baseline findings and sex differences from the multicenter TEACH trial
    Christoph Herrmann‐Lingen, Monika Sadlonova, Ingrid Becker, Kristina Bersch, Franziska Geiser, Martin Hellmich, Ingrid Kindermann, Matthias Michal, Mariel Nöhre, Astrid Petersmann et al. · 2025 · Frontiers in Psychiatry
93. Association Between Age at Diagnosis of Coronary Heart Disease and Incident Depression and Anxiety
    Jie Liang, Qiongwei Li, Yang Pan, Wenya Zhang, Darui Gao, Yanyu Zhang, Jingya Ma, Yuling Liu, Yiwen Dai, Mengmeng Ji et al. · 2025 · Acta Psychiatrica Scandinavica
94. Real-World Predictor Factors and Clinical Outcomes in Patients With Major Depressive Disorder Undergoing Percutaneous Coronary Intervention: Rationale and Study Protocol for the PCI CODE Study
    Jiang Wei Xiao, Jun Wang, Tian Xu, Junjie Zhang, Xiaodong Mu, Jing Kan, Fei Ye, Xiaofei Gao, Nailiang Tian, Song Lin et al. · 2025 · Cardiology Discovery
95. Additional file 1 of Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance
    Macchi, C., C. Favero, Ceresa, A., Vigna, L., Conti, D. M., Pesatori, A. C., Racagni, G., A. Corsini, Ferri, N., Sirtori, C. R. et al. · 2020 · Figshare
96. Depression bei somatischen Erkrankungen
    Woo Ri Chae, Christian Otte · 2025 · InFo Neurologie + Psychiatrie
97. Efficacy and Safety of Escitalopram in Alleviating Depression and Anxiety Symptoms in COPD Patients: A Randomized Double-Blind Placebo-Controlled Trial
    Zhan Gao, Shasha Tang, Wen Zhang, Mingzhou Zhang, Zhenghua Wei, Zhou Long, Bin Wang, Heng Qin, Hang Qian, Yan Yin et al. · 2026 · International Journal of COPD
98. Postmyocardial Infarction Depression as a Modifiable Secondary Prevention Risk Factor.
    A. Arun, Elizabeth Abraham, Madiha Baig, A. Arun, W. Frishman · 2026 · Cardiology in Review
99. Inhibition of the serotonin transporter and risk of heart valve disease: A systematic review and meta-analysis
    Anthony Campbell, Arianna Adamo, Emre Bektik, Yaagnik Kosuri, Cary Karcher, Dov Levine, Rajasekhar Ramakrishnan, Juan B Grau, Robert J. Levy, Giovanni Ferrari · 2026 · European Journal of Pharmacology
100. Genetic perspectives on the comorbidity of anxiety and mood disorders with cardiovascular disease
     Eco J. C. de Geus, Jorien L. Treur, Brenda W.J.H. Penninx · 2026 · Nature Cardiovascular Research